Novabay Pharmaceuticals, Inc. [NBY] has reported $2.6 million in revenue Gross profit for Q4 ended Dec 31, 2022.
The company said in a filing before the Securities and Exchange Commission that its loss Net loss for the quarter was $3.2 million.
Based in EMERYVILLE, California, Novabay Pharmaceuticals, Inc. operates in the Manufacturing sector.